Previous study has revealed that IGF2BPs contribute to mRNA stability [38] and IGF2BP1 and IGF2BP3 are associated with poor disease outcome in ovarian cancer [39, 40]. This evidence concerns the gene IGF2BP3 and ovarian carcinoma.